ATE524542T1 - Aus knochenmarksstützzellen stammende schwann'sche zellen - Google Patents

Aus knochenmarksstützzellen stammende schwann'sche zellen

Info

Publication number
ATE524542T1
ATE524542T1 AT02738782T AT02738782T ATE524542T1 AT E524542 T1 ATE524542 T1 AT E524542T1 AT 02738782 T AT02738782 T AT 02738782T AT 02738782 T AT02738782 T AT 02738782T AT E524542 T1 ATE524542 T1 AT E524542T1
Authority
AT
Austria
Prior art keywords
cells
differentiation
schwann
myeloid
medium
Prior art date
Application number
AT02738782T
Other languages
English (en)
Inventor
Mari Dezawa
Hajime Sawada
Masahiko Takano
Original Assignee
Sanbio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanbio Inc filed Critical Sanbio Inc
Application granted granted Critical
Publication of ATE524542T1 publication Critical patent/ATE524542T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/383—Nerve cells, e.g. dendritic cells, Schwann cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3878—Nerve tissue, brain, spinal cord, nerves, dura mater
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
AT02738782T 2001-06-22 2002-06-21 Aus knochenmarksstützzellen stammende schwann'sche zellen ATE524542T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001190251A JP3886346B2 (ja) 2001-06-22 2001-06-22 骨髄間質細胞由来Ｓｃｈｗａｎｎ細胞を含む神経再生用医薬組成物
PCT/JP2002/006249 WO2003000871A1 (fr) 2001-06-22 2002-06-21 Cellules de schwann provenant de cellules myeloides interstitielles

Publications (1)

Publication Number Publication Date
ATE524542T1 true ATE524542T1 (de) 2011-09-15

Family

ID=19029054

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02738782T ATE524542T1 (de) 2001-06-22 2002-06-21 Aus knochenmarksstützzellen stammende schwann'sche zellen

Country Status (8)

Country Link
US (2) US6989271B2 (de)
EP (2) EP2345715A3 (de)
JP (1) JP3886346B2 (de)
AT (1) ATE524542T1 (de)
CA (1) CA2450789C (de)
DK (1) DK1405906T3 (de)
ES (1) ES2369259T3 (de)
WO (1) WO2003000871A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050265983A1 (en) * 2002-11-17 2005-12-01 Eldad Melamed Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
ES2524996T3 (es) 2005-06-16 2014-12-16 Ramot At Tel Aviv University Ltd. Células aisladas y poblaciones que comprenden a las mismas para el tratamiento de enfermedades del SNC
JP5662147B2 (ja) * 2007-08-15 2015-01-28 サンバイオ，インコーポレイティド 神経変性を治療するための方法及び組成物
US8283160B2 (en) 2007-09-11 2012-10-09 Frey Ii William H Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system
KR100973324B1 (ko) 2007-11-23 2010-07-30 재단법인서울대학교산학협력재단 사람 중간엽 줄기세포에서 운동 신경세포로의 분화 유도방법
PL2222839T3 (pl) 2007-12-03 2016-02-29 Sanbio Inc Sposoby i kompozycje do modulowania i różnicowania pluripotencjalnych komórek
ES2594229T3 (es) 2008-04-30 2016-12-16 Sanbio, Inc. Células de regeneración nerviosa con alteraciones en la metilación del ADN
DK2620493T3 (da) 2008-05-28 2019-07-01 Univ Ramot Mesenkymale stamceller til behandling af CNS-sygdomme
US20120263681A1 (en) * 2011-04-12 2012-10-18 Fujifilm Corporation Composition comprising cell and biocompatible polymer
EP2806881A1 (de) 2012-01-27 2014-12-03 SanBio, Inc. Verfahren und zusammensetzungen zur modulation der angiogenese und vaskulogenese
CN104519891B (zh) 2012-05-16 2019-03-22 桑比欧公司 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物
US9326999B2 (en) 2012-10-09 2016-05-03 Sanbio, Inc. Methods and compositions for treatment of retinal degeneration
US10675382B2 (en) * 2014-09-12 2020-06-09 Kyoto Prefectural Public University Corporation Schwann cells and method for preparing same
WO2017147491A1 (en) * 2016-02-25 2017-08-31 University Of Miami Production of schwann cells
CA3047329A1 (en) 2016-12-28 2018-07-05 Sanbio, Inc. Cell delivery system and methods of operation thereof
CN109609456B (zh) * 2018-12-21 2022-06-21 首都医科大学附属北京潞河医院 一种雪旺细胞来源外泌体的用途、诱导剂和试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165747A (en) * 1993-12-30 2000-12-26 President & Fellows Of Harvard College Nucleic acids encoding hedgehog proteins
US5849585A (en) * 1995-05-10 1998-12-15 Genetech, Inc. Isolating and culturing Schwann cells
US5714385A (en) * 1995-05-10 1998-02-03 Genentech, Inc. Media for culturing schwann cells
JP5943533B2 (ja) * 2000-05-17 2016-07-06 アステリアス バイオセラピューティクス インコーポレイテッド 神経前駆細胞の集団
US6543819B2 (en) * 2001-04-02 2003-04-08 John Hakimain Necktie knotter
US20030220280A1 (en) * 2002-02-07 2003-11-27 Bunge Mary Bartlett Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate CNS nerve regeneration

Also Published As

Publication number Publication date
CA2450789C (en) 2007-09-04
US20050255593A1 (en) 2005-11-17
EP2345715A2 (de) 2011-07-20
US6989271B2 (en) 2006-01-24
ES2369259T3 (es) 2011-11-28
EP1405906A1 (de) 2004-04-07
EP1405906B1 (de) 2011-09-14
DK1405906T3 (da) 2011-12-12
CA2450789A1 (en) 2003-01-03
US20040197309A1 (en) 2004-10-07
JP3886346B2 (ja) 2007-02-28
WO2003000871A1 (fr) 2003-01-03
EP2345715A3 (de) 2013-02-13
JP2003061647A (ja) 2003-03-04
EP1405906A4 (de) 2008-03-19

Similar Documents

Publication Publication Date Title
ATE524542T1 (de) Aus knochenmarksstützzellen stammende schwann'sche zellen
Swanson et al. Macropore design of tissue engineering scaffolds regulates mesenchymal stem cell differentiation fate
Brennan et al. Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate
Grzesik et al. Cementum and periodontal wound healing and regeneration
RU2375447C2 (ru) СПОСОБ ПОЛУЧЕНИЯ ХОНДРО-ОСТЕОГЕННЫХ КЛЕТОК in vitro ИЗ МЕЗЕНХИМНЫХ СТВОЛОВЫХ КЛЕТОК ЧЕЛОВЕКА И ИХ ПРИМЕНЕНИЕ
Mansilla et al. Cadaveric bone marrow mesenchymal stem cells: first experience treating a patient with large severe burns
AU1615599A (en) Differentiation of adipose stromal cells into osteoblasts and uses thereof
PL2233150T3 (pl) Erytropoetyna do zastosowania w leczeniu ran lub transplantacji komórek
CN101384702A (zh) 间充质干细胞及其用途
Lu et al. Translational research and therapeutic applications of stem cell transplantation in periodontal regenerative medicine
Freitas et al. Cell therapy: effect of locally injected mesenchymal stromal cells derived from bone marrow or adipose tissue on bone regeneration of rat calvarial defects
Ortiz et al. Effects of therapy with fibrin glue combined with mesenchymal stem cells (MSCs) on bone regeneration: a systematic review
CN107354127B (zh) LncRNA-TUG1在调控PDLSCs成骨分化及组织再生中的作用
DE69634982D1 (de) Verfahren zur steigerung von hematopoietischen zellen
JP3680067B2 (ja) 移植用軟骨細胞の製法
Chen et al. Directional homing of glycosylation-modified bone marrow mesenchymal stem cells for bone defect repair
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
Al-Qadhi et al. The gingiva from the tissue surrounding the bone to the tissue regenerating the bone: a systematic review of the osteogenic capacity of gingival mesenchymal stem cells in preclinical studies
Imran et al. Regenerative medicine therapy in Malaysia: An update
KR102257386B1 (ko) 줄기세포 재료 및 그 제조방법
Abe et al. Bone regeneration in a canine model of artificial jaw cleft using bone marrow–derived mesenchymal stem cells and carbonate hydroxyapatite carrier
Chen et al. Low-intensity pulsed ultrasound promotes mesenchymal stem cell transplantation-based articular cartilage regeneration via inhibiting the TNF signaling pathway
KR101389851B1 (ko) 신경능선줄기세포의 배양방법 및 그 용도
CN106434543A (zh) 一种培养基及细胞培养方法
Zhang et al. Extracellular vesicles derived from human dental mesenchymal stem cells stimulated with low-intensity pulsed ultrasound alleviate inflammation-induced bone loss in a mouse model of periodontitis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties